Blocking a tumor ‘shield’ protein may boost immunotherapy before bladder surgery
In a small phase 2a trial published Oct. 24, 2026, in Nature Medicine, adding visugromab, which blocks the protein GDF-15, to nivolumab before bladder surgery led to no remaining cancer in 33%…
